Mark D. Stolper
Independent DirectorMr. Mark D. Stolper is Executive VP & CFO of Radnet Management, Inc. Mr. Stolper has B.A. in Economics, Economics from University of Pennsylvania. Mr. Stolper is Independent Director of Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) from January 2, 2026. Mr. Stolper is Director of Envision Healthcare Corporation from January 2024. He served as an Independent Director at Coherus BioSciences, Inc. since January 05, 2021 until May 2025. He serves as Non-Employee Independent Director of Rotech Healthcare Holdings Inc. since April 2016. He has been Chief Financial Officer and Executive Vice President of RadNet, Inc. since July 2004. He serves as a Director of Rotech Healthcare Inc, a privately held medical equipment company, since February 2016. Mr. Stolper was employed at Dillon Read Capital Management LLC. Prior to joining RadNet, he has diverse experiences in investment banking, private equity, venture capital investing and operations. From 1999 to 2004, he was a Founding Partner/Partner of Broadstream Capital Partners, LLC and West Coast Capital from 1999 to 2004. In 1999, Mr. Stolper co-founded Broadstream Capital Partners. He worked at Saratoga Partners and Archon Capital, L.P. He started his career as a member of the corporate finance group at Dillon, Read & Co. Inc. from 1993 to 1995, executing mergers and acquisitions, public and private financings and private equity investments with Saratoga Partners LLP. Mr. Stolper worked in business development for Eastman Kodak Company from 1997 to 1999. He also previously served as Vice President of Eastman Kodak Co.’s Entertainment Imaging subsidiary from 1998 to 1999 and as Vice President at Archon Capital Partners, from 1995 to 1998. He has been Independent Director of Surgalign Holdings, Inc. since March 2017 and served as its Lead Independent Director since July 24, 2020. He served as an Independent Director of On Track Innovations Ltd., from December 30, 2012 to 2016. He was an Independent Director at Surgical Solutions, LLC since January 2015 until February 2017. He served as a Director of ALCO Stores, Inc. from August 29, 2014 until June 2015. He served as the Chairman of Compumed Inc. from May 2007 to October 2014. He served as a Director of Physiotherapy Associates, Inc. from December 2013 to February 2016. He served as a Director of Metropolitan Health Networks Inc. since April 23, 2010 until December 2012 and CompuMed Inc., from 2008 to 2014. He served as a Member of the Board of RadNet, Incorporated from March 2004 to July 2004. From 1995 to 1997, Mr. Stolper was a member of Archon Capital Partners. He served as a Director of Tix Corporation from July 2011 to December 24, 2013. Previously, Mr. Stolper served as a member of the board of directors of 21st Century Oncology Holdings, Inc. from January 2018 to May 2020. He was a member of the board of directors for a privately held entertainment company providing discount ticketing services and branded event merchandising and was Chairman of the board for a private telemedicine and eHealth provider. Mr. Stolper holds a B.A. in Economics from the University of Pennsylvania and a B.S.E. in Finance from the Wharton School. Additionally, he holds a postgraduate Award in Accounting from the University of California, Los Angeles.
Positions
- Company NameStarling Oncology, Inc.Stock CodeSTLNPositionIndependent DirectorColleagues
- DVDaniel VirnichCEO & Executive Director
- AMAnne M. McGeorgeIndependent Chairman
- RCRobert CarterChief Financial Officer
- YDYale D. PodnosChief Medical Officer
- ALAustin LeeVP of Accounting & Controller
- RPRakesh PandaChief Information Officer
- KMKaren Marie Walker JohnsonIndependent Director
- MKMohit KaushalIndependent Director
- Company NameRadNet, Inc.Stock CodeRDNTPositionExecutive VP & CFOColleagues
- HGHoward G. BergerChairman, President & CEO
- MDMark D. StolperExecutive VP & CFO
- MPMital PatelExecutive VP & COO
- NRNorman R. HamesPresident & CEO of Western Operations
- SMStephen M. ForthuberPresident & CEO of Eastern Operations
- AGAlma Gregory SorensenExecutive VP, Chief Strategy Officer & Director
- DLDavid L. SwartzLead Independent Director
- LLLawrence L. LevittIndependent Director
- LPLaura Pastre JacobsIndependent Director
